Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ophthalmol Retina ; 6(7): 595-606, 2022 07.
Article in English | MEDLINE | ID: mdl-35304304

ABSTRACT

PURPOSE: To determine the practice pattern for treating giant retinal tear (GRT) related detachments, and their anatomic and visual outcomes with pars plana vitrectomy (PPV) with or without scleral buckling (SB). DESIGN: Retrospective cohort study. SUBJECTS: Eyes with GRT detachments repaired from 2008 to 2020 with at least 6 months of follow-up from 7 institutions in North and South America, Europe, and Asia. METHODS: Eyes repaired using PPV versus PPV/SB were compared. MAIN OUTCOME MEASURES: Anatomic and functional outcomes. RESULTS: A comparable number of eyes underwent PPV (n = 101) and PPV/SB (n = 99). Except for history of developmental abnormalities, prior intraocular surgery, and lens status, no differences in baseline demographics, ocular characteristics, or intraoperative surgical adjuncts were observed. The overall single surgery anatomic success (SSAS) at 6 months and 1 year were similar between the groups (82.2% and 77.2% of PPV, and 87.9% and 85.7% of PPV/SB). When stratified by age, the 1-year SSAS rate was higher for PPV/SB (88.5%) than PPV (56.3%) (P = 0.03) for children <18 years. For both children and adults, the mean best-corrected visual acuity (BCVA) at baseline did not differ between the PPV and PPV/SB groups. However, for children, mean BCVA at 1 year was better in the PPV/SB than PPV groups (P = 0.001) while for adults, no difference was found between the 2 groups. The mean time to the first redetachment was 7.9 months in the PPV group and 5.5 months in the PPV/SB group (P = 0.8). Proliferative vitreoretinopathy was the most common cause for redetachment (70.4% of PPV and 93.8% of PPV/SB in redetached eyes; P = 0.1). Postoperative complications were also similar between the 2 groups, including ocular hypertension, epiretinal membrane, and cataract formation. CONCLUSIONS: PPV and PPV/SB are equally popular among surgeons globally for managing GRT detachments and have comparable anatomic and visual outcomes in adults. In children, PPV/SB is superior to PPV for anatomic and functional success at 1 year. In adults, the relief of traction by the GRT may reduce peripheral traction and obviate the need for an SB. However, in children, a supplemental SB can be beneficial as complete vitreous shaving and posterior hyaloid detachment, and postoperative positioning, are difficult in this group.


Subject(s)
Retinal Detachment , Retinal Perforations , Adult , Child , Humans , Infant , Retinal Detachment/diagnosis , Retinal Detachment/etiology , Retinal Detachment/surgery , Retinal Perforations/complications , Retinal Perforations/diagnosis , Retinal Perforations/surgery , Retrospective Studies , Scleral Buckling/adverse effects , Treatment Outcome , Visual Acuity , Vitrectomy/adverse effects
2.
Ocul Immunol Inflamm ; 28(7): 1129-1132, 2020 Oct 02.
Article in English | MEDLINE | ID: mdl-31419162

ABSTRACT

Purpose: To report acute photoreceptor layers loss in Behcet's disease and its anatomical recovery after treatment with systemic steroids, mycophenolate mofetil, and adalimumab. Methods: Case report. Results: A 16-year-old male who presented with an acute attack of Behcet's panuveitis along with loss of the ellipsoid zone (EZ) and interdigitation zone (IZ) on optical coherence tomography (OCT). Treatment resulted in complete recovery of photoreceptors and improvement in vision. Conclusion: Acute photoreceptor layers loss could be a manifestation of Behcet's uveitis and anatomical recovery may be achieved with aggressive and timely treatment.


Subject(s)
Behcet Syndrome/drug therapy , Glucocorticoids/therapeutic use , Photoreceptor Cells, Vertebrate/drug effects , Retinal Pigment Epithelium/drug effects , Acute Disease , Adalimumab/therapeutic use , Administration, Ophthalmic , Administration, Oral , Adolescent , Anti-Inflammatory Agents/therapeutic use , Behcet Syndrome/diagnostic imaging , Enzyme Inhibitors/therapeutic use , Fluorescein Angiography , Humans , Infusions, Intravenous , Male , Methylprednisolone/therapeutic use , Mycophenolic Acid/therapeutic use , Ophthalmic Solutions , Photoreceptor Cells, Vertebrate/pathology , Prednisolone/therapeutic use , Retinal Pigment Epithelium/diagnostic imaging , Tomography, Optical Coherence , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...